These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10091798)

  • 1. p53 protein expression in squamous cell carcinoma of the vulva.
    Scheistrøen M; Tropé C; Pettersen EO; Nesland JM
    Cancer; 1999 Mar; 85(5):1133-8. PubMed ID: 10091798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.
    Fonseca-Moutinho JA; Coelho MC; Silva DP
    J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 protein expression in a population-based series of primary vulval squamous cell carcinoma and immediate adjacent field change.
    McConnell DT; Miller ID; Parkin DE; Murray GI
    Gynecol Oncol; 1997 Dec; 67(3):248-54. PubMed ID: 9441771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
    Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
    J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva.
    Tempfer C; Gitsch G; Haeusler G; Reinthaller A; Koelbl H; Kainz C
    Cancer; 1996 Jul; 78(2):273-7. PubMed ID: 8674003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 overexpression is not an independent prognostic factor for patients with primary ovarian epithelial cancer.
    Eltabbakh GH; Belinson JL; Kennedy AW; Biscotti CV; Casey G; Tubbs RR; Blumenson LE
    Cancer; 1997 Sep; 80(5):892-8. PubMed ID: 9307189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of p63 and p53 expression in upper urinary tract transitional cell carcinoma.
    Zigeuner R; Tsybrovskyy O; Ratschek M; Rehak P; Lipsky K; Langner C
    Urology; 2004 Jun; 63(6):1079-83. PubMed ID: 15183954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the adhesion molecule CD44v3 is a prognostic factor in vulvar carcinoma.
    Tempfer C; Gitsch G; Hanzal E; Reinthaller A; Koelbl H; Kainz C
    Anticancer Res; 1996; 16(4A):2029-31. PubMed ID: 8712738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery.
    Zhu Y; Zhou XY; Yao XD; Dai B; Ye DW
    BJU Int; 2007 Jul; 100(1):204-8. PubMed ID: 17433031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invasive squamous cell carcinoma of vulva: prognostic significance of clinicopathologic parameters.
    Nola M; Blazanovic A; Dotlic S; Morovic A; Tomicic I; Jukic S
    Croat Med J; 2005 Jun; 46(3):436-42. PubMed ID: 15861524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients.
    Preti M; Ronco G; Ghiringhello B; Micheletti L
    Cancer; 2000 Apr; 88(8):1869-76. PubMed ID: 10760764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
    Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
    Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
    Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutant p53 in patients with invasive cervical cancer stages IB to IIB.
    Kainz C; Kohlberger P; Gitsch G; Sliutz G; Breitenecker G; Reinthaller A
    Gynecol Oncol; 1995 May; 57(2):212-4. PubMed ID: 7729736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
    Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
    Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
    Garcia del Muro X; Condom E; Vigués F; Castellsagué X; Figueras A; Muñoz J; Solá J; Soler T; Capellà G; Germà JR
    Cancer; 2004 May; 100(9):1859-67. PubMed ID: 15112266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of epithelial disorders adjacent to invasive vulvar carcinomas.
    Rouzier R; Morice P; Haie-Meder C; Lhomme C; Avril MF; Duvillard P; Castaigne D
    Gynecol Oncol; 2001 Jun; 81(3):414-9. PubMed ID: 11371131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.